CONTINUOUS PATIENT INSIGHT Trademark

Trademark Overview

On Tuesday, March 13, 2018, a trademark application was filed for CONTINUOUS PATIENT INSIGHT with the United States Patent and Trademark Office. The USPTO has given the CONTINUOUS PATIENT INSIGHT trademark a serial number of 87832211. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, December 1, 2020. This trademark is owned by PhysIQ, Inc.. The CONTINUOUS PATIENT INSIGHT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
continuous patient insight

General Information

Serial Number87832211
Word MarkCONTINUOUS PATIENT INSIGHT
Filing DateTuesday, March 13, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, December 1, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2018

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 20, 2018
Primary Code042
First Use Anywhere DateMonday, March 5, 2018
First Use In Commerce DateMonday, March 5, 2018

Trademark Owner History

Party NamePhysIQ, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNaperville, IL 60563
Party NamePhysIQ, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNaperville, IL 60563

Trademark Events

Event DateEvent Description
Tuesday, December 1, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, December 1, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 7, 2020NON-FINAL ACTION E-MAILED
Thursday, May 7, 2020SU - NON-FINAL ACTION - WRITTEN
Wednesday, December 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 3, 2019NON-FINAL ACTION E-MAILED
Monday, June 3, 2019SU - NON-FINAL ACTION - WRITTEN
Tuesday, April 23, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 9, 2019USE AMENDMENT FILED
Sunday, April 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 9, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, October 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 14, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 14, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, June 24, 2018ASSIGNED TO EXAMINER
Tuesday, March 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 16, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

insight patient continuous pharmaceuticals clinical trials field information medical scientific research providing